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The mechanisms of liver injury in chronic hepatitis C virus (HCV) infection are poorly understood though HCV induces a state of hepatic
oxidative stress that is more pronounced than that present in many other inflammatory diseases. This mini-review will focus on recent findings
revealing an unexpected role of mitochondria in providing a central role in the innate immunity and in addition will illustrate the application of
stably transfected human-derived cell lines, inducibly expressing the entire HCVopen reading frame for in vitro studies on mitochondria. Results
obtained by a comparative analysis of the respiratory chain complexes activities along with mitochondrial morpho-functional confocal microscopy
imaging show a detrimental effect of HCV proteins on the cell oxidative metabolism with specific inhibition of complex I activity, decrease of
mtΔΨ, increased production of reactive oxygen species. A possible de-regulation of calcium recycling between the endoplasmic reticulum and the
mitochondrial network is discussed to provide new insights in the pathogenesis of hepatitis C.
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The hepatitis C virus (HCV) is a significant health
problem worldwide. More than 170 million people, or 3%
of the world population, are infected with HCV [1]. HCV
infection causes acute hepatitis which is naturally cleared in
20–30% of patients. However in 70–80% of cases, HCV
persists causing chronic hepatitis [2]. Cycles of hepatocyte
death and regeneration occur and activation of stellate cells
results in formation of abnormal extracellular matrix. These
effects result in progressive fibrosis and carcinogenesis. As a
consequence chronic hepatitis can lead to a spectrum of
diseases including, fibrosis, cirrhosis and hepatocellular
carcinoma [2]. There is no effective vaccine available and
current therapies show limited efficacy for many HCV-
infected patients [3].
HCV is an enveloped, positive-strand RNA virus and its
RNA genome is about 9600 nucleotides in length [4,5]. It
carries 5′ and 3′ non coding regions flanking a large open⁎ Corresponding author. Tel.: +39 0881 711148; fax: +39 0881 714745.
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doi:10.1016/j.bbabio.2006.05.018reading frame, which encodes a polyprotein of more than
3000 amino acid residues (Fig. 1). The 5′ NCR contains an
internal ribosome entry site that directs the translation of the
HCV polyprotein at the level of the endoplasmic reticulum
(ER). This polyprotein is cleaved co- and post-translationally
by host and viral proteases producing 3 structural proteins
(core, E1 and E2) and 7 nonstructural proteins [4,5]. The
nonstructural proteins orchestrate viral replication forming a
membrane associated replication complex. With the excep-
tion of E1 and E2, which face the ER lumen, all the other
HCV proteins are mainly exposed to the cytosolic space and
are anchored to the ER membrane by specific membrane
segments [6].
2. Mitochondria in the innate immunity (MAVS vs. NS3/4a)
Very recently, an unexpected finding has revealed for
mitochondria a central role in the innate immunity response
of cell to virus infection. Virus infection is known to result
in the activation of multiple pathways leading to the
expression of genes whose products have inhibitory activity
on the viral replication/transcription machinery. A newly
discovered protein called MAVS (also named CARDIF,
Fig. 1. Hepatisis C virus (HCV) features. Genome organization and schematic representation of the HCV structural proteins (C, E1 and E2) and non-structural proteins
(p7, NS2, NS3, NS4A, NS4B, NS5A and NS5B) as the proteins associate with the endoplasmic reticulum. The function of the non-structural proteins is also indicated.
Another HCV protein named “F” might also be synthesized by a ribosomal frameshift in the core coding sequence. E1 and E2 are N-glycosylated. 5′ and 3′NCR, non
coding region; IRES, internal ribosome entry site. Initially, the HCV virus recognizes and is incorporated into human liver cells. The internalized virus then dissociates,
liberating the viral RNA genome. The HCV RNA is then translated by the host ribosomes, producing the HCV polypeptide. This polypeptide is subsequently
processed, first by host peptidases then by the HCV proteases (NS2 and NS3) into 10 different HCV proteins. The non-structural proteins (NS2–NS5b) are next
assembled and localized within the liver cell to form a replication complex, which produces multiple copies of the HCV RNA genome. These RNA copies are then able
to re-enter the life cycle, producing more HCV proteins. Eventually, the HCV structural proteins (C, E1 and E2) along with copies of the HCV RNA are packaged as
infectious virus particles, released from the liver cell, and are able to infect new cells.
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required for the activation of IFN-β. This protein is located
at the outer mitochondrial membrane where it is anchored
by a C-terminal TM helix (Fig. 2). An upstream receptorcalled RIG-I acts as a sentinel detecting the presence of
viral replication intermediates, such as dsRNA. RIG-I binds
to dsRNA and interacts with MAVS, the so formed
heterocomplex, recruiting different clusters of adapters,
Fig. 2. Schematic drawing illustrating the proposed role of mitochondria in the
innate immunity and the strategy used by HCV to evade it. Viral infection
results in the activation of multiple pathways. The MAVS (mitochondrial
antiviral signalling) protein coordinates upstream events leading to activation
of the interferon-β (IFN-β). MAVS (also known as IPS-1, VISA and
CARDIF) is localized at the outer mitochondrial membrane where it is
anchored by a transmembrane helix. The presence of viral RNA replication
products is sensed by the cytosolic protein RIG-I (retinoic acid induced gene
I) which contains a RNA helicase domain that binds to dsRNA. RIG-I also
contains tandem N-terminal caspase recruitment domains (CARDs) that
interact with another CARD domain present in the MAVS protein. Binding of
RIG-I complexed to dsRNA to MAVS activates downstream signalling
pathways. These include activation of the IKK (inhibitor κB kinase) complex
(which regulate NF-κB (nuclear factor κB)) and of the non “canonical” kinase
TBK-1 (which regulates IRF3/7 (IFN regulatory factor 3/7)). Activation of
these transcription factors and their translocation to the nucleus leads to
assembly of a multiprotein enhancer complex, the enhanceosome, which
drives expression of IFN-β gene. Importantly, the mitochondrial localization
of MAVS is essential for its signalling function, because the removal of the
mitochondrial targeting domain of MAVS abolishes its function to induce
IFNs. The HCV protein NS3/4A (which is a serine protease) cleaves MAVS
at Cys-508, resulting in dislocation of the N-terminal fragment of MAVS
from the mitochondria. Point mutation of MAVS at Cys-508 renders MAVS
resistant to cleavage by NS3/4A, thus maintaining the ability of MAVS to
induce interferons in HCV replicon cells. The physical interaction between
the ER-bound NS3/4A and the mitochondria-bound MAVS might be provided
by contiguity at localised contact sites of the ER-mitochondria networks or by
transient membrane fusion-driven intermembrane protein transfer. Drawn
from the evidence reported in Refs. [7–11].
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ultimately result in the activation of IRF-3/7 and NF-κB.
These transcription factors assemble in an enhansosome
driving the expression of IFN-β. Moreover it has been
found that one of the nonstructural HCV protein NS 3/4A is
able to cleave MAVS (CARDIF) at a specific cysteine
residue resulting in its inactivation. This enables HCV to
block the MAVS-down-stream signalling pathway and evade
the host innate immunity. Mutation of MAVS at that specificcysteine residue confers resistance of cell to HCV infection
[10,11].
Besides this very new immunological role of mitochondria a
large body of evidence have been accumulating over the time
providing clues for a substantial alteration in the mitochondrial
oxidative metabolism although the mechanism has remained
elusive [12,13].
3. Cell lines allowing regulated expression of HCV proteins:
principles and applications
The lack of an efficient cell culture system, permissive
for hepatitis C virus infection and replication, has limited
the systematic study of the viral life cycle, pathogenetical
mechanisms as well as the development and evaluation of
novel antiviral strategies. Infection of primary hepatocytes or
transient expression of subgenomic or entire HCV replicons
yield only low levels and often poorly reproducible viral
replication [4,5]. An alternative approach, more recently
developed, involves the generation of cell lines stably
expressing viral sequences from chromosomally integrated
cDNA constructs [14]. A recent major breakthrough in this
direction has been the use of a gene expression system
based on regulatory elements of the tetracycline (TET)-
resistence operon of E. coli (illustrated in Fig. 3A) [15–17].
Inducible cell lines were generated by two successive
transfection and selection steps. A founder cell line
constitutively expressing the TET-controlled trans-activator
was established first, followed by a stable transfection of the
cDNA construct, harbouring the HCV genome, under the
transcriptional control of a TET-controlled transactivator-
dependent promoter. More importantly, steady state HCV
gene expression can, not only be switched on and off, but
fine-tuned over a broad range by varying the concentration
of TET in the culture medium.
Fig. 3B shows the modulation of the HCV protein expression
in the human-derived osteosarcoma cell line U-2 OS. Immuno-
blotting against three of the HCV proteins was undetectable in the
non-induced cell line their expression becoming clearly evident
following a 48 h withdrawal of TET from the medium. A sta-
tionary expressionwas reached even earlier (data not shown). The
expression and intracellular localization of the induced proteins
was further verified by confocal microscopy immuno-cytochem-
istry. The representative images shown in Fig. 3B refer to the
structural HCV core protein. It can be seen that the core protein
localizes in a web resembling the endoplasmic reticulum. To no-
tice, a more evident spotted structure, is also observed that might
indicate the concentration of the HCV proteins in lipid droplets as
well documented by immunohistochemical analysis carried out
on bioptic reports from infected patients [4,5].
4. Effect of HCV-protein expression on the mitochondrial
OXPHOS system
By exploiting this well controlled cell culture system, we
studied the effect of the expressed HCV proteins on the
mitochondrial OXPHOS system. Differently from other
Fig. 3. Regulated HCV-gene expression in U-2 OS-derived cell line. (A) Tetracycline-regulated gene expression system. The system consists of a tetracycline-
controlled transactivator (rTA), which is composed of the tetracycline repressor (tet R) fused to the activating domain of VP16 of herpes simplex virus, and of a tTA-
dependent promoter, which is composed of a minimal sequence derived from the cytomegalovirus intermediate early promoter (CMV P) combined with heptameric
tetracycline operator (tet O) sequences. The tTA-dependent promoter is virtually silent in many cell types in the presence of low concentrations of tetracycline (TET),
which prevent the tTA from binding to tet O sequences. In the absence of tetracycline, the tTA binds to the tet O sequences to activate transcription from the minimal
promoter. (B) Tightly regulated expression of HCV proteins in U-2 OS cell line. U-2 OS cells were cultured in DMEM supplemented with 10% FBS in the presence of
1 μg/ml tetracycline. Subsequently, in one sample the medium was changed with withdrawal of tetracycline (TET−) and in the other the medium was replaced without
omitting tetracycline. After 48 h the cell samples were harvested and assayed. Panel on the left: proteins from cell lysate were separated by 12% SDS-PAGE and
analysed by immunoblot with a pool of monoclonal antibodies against core, NS3, NS5b and β-actin. Right panel: immuno-cytochemical detection of HCV-core
protein by laser scanning confocal microscopy (LSCM). U-2 OS cells, cultured at low density onto fibronectin coated 35 mm glass bottom dishes as described before,
were fixed (4% paraformaldehyde), permeabilised (0.2% Triton X-100), blocked (3% BSA in PBS), and then sequentially incubated with diluted mouse monoclonal
anti-core and secondary Rhodamine-conjugated goat anti-mouse IgG. Subsequently cells were treated for nuclear staining with 1 μM Topro-1. Then after cells were
examined by a Nikon TE 2000 microscope (images collected using a 60X objective 1.4 NA) coupled to a Radiance 2100 dual laser scanning confocal microscopy
system (Biorad). The fluorescence signals of Rhodamine and Topro-1 were monitored sequentially exciting first with the He–Ne laser beam (λex=543 nm) and then
with the Ar–Kr laser beam (λex=514 nm) respectively. Magnification of the selected area (indicated by the white frame) is shown for the HCV-induced U-2 OS cell
sample. The images are representative of three different preparations. Analogous results were obtained for the immuno-localization of the HCV-NS2 protein. Scale
bars: 20 μm.
1432 C. Piccoli et al. / Biochimica et Biophysica Acta 1757 (2006) 1429–1437similar studies, which used transfected cells overexpressing
subgenomic HCV constructs, our cell system allows to
evaluate the effects caused by the co-ordinated expression of
the entire HCV polyprotein thus constituting a betterphysiological simulation of HCV infection. Of notice, the
biological activity of some of the HCV proteins depends on
the co-expression of others [4–6]. Fig. 4A shows the results
of a respirometric analysis carried out on intact U-2 OS-
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found significantly decreased by a 40% in cells expressing
the HCV proteins. Addition of oligomycin strongly reduced
the oxygen consumption rates more in the control than in
the induced cells so that the relative respiratory control ratio
resulted markedly depressed in cells expressing the HCV
genome. Incubation of the induced cells with cyclosporine A
was ineffective (not shown).
Fig. 4B illustrates the results of a comparative confocal
microscopy analysis of the mitochondrial morpho-functional
pattern. Using a specific ratiometric dual emitter probe
(MitoCapture) it was possible to unveil a profound difference.
While in the control cells the almost entire intracellular
mitochondrial network was able to generate and maintain
relatively high mtΔΨ, the HCV-induced cells showed afunctional mitochondrial heterogeneity with many hypo-
polarized mitochondria, thus confirming the respiratory
measurements. Other specific mitochondrial probes showed
that the overall mitochondrial content and architecture was,
however, unchanged exhibiting both in the control and in the
HCV-induced U-2 OS derived cell lines a well-defined
reticular net (not shown).
Fig. 4C shows that measurements of the specific
activities of the proton pumping respiratory complexes
resulted in inhibition of complex I in the HCV-induced
cells to an extent comparable with that observed for the
endogenous respiration. Conversely, the activities of com-
plexes III and IV were slightly increased, albeit within the
statistical significance, perhaps reflecting some kind of
compensatory attempt.
These results show that expression of HCV polyprotein
causes an apparent decrease of the OXPHOS coupling
efficiency together with an effect on the activity of complex
I that manifest on the overall cell respiratory rate.Fig. 4. Functional analysis of HCV protein induction in U-2 OS-derived cell
line on the mitochondrial OXPHOS system. (A) Measurements of oxygen
consumption in intact cells. 5–7 106 viable cell/ml was assayed
polarographycally in 50 mM KPi, 10 mM HEPES, 1 mM EDTA, pH
7.4; after establishment of a stationary endogenous respiratory rate 2 μg/ml
of oligomycin was added. Both rates of O2 consumption were corrected for
2 mM KCN-insensitive respiration. RCR: respiratory control ratio obtained
dividing the rates of oxygen consumption attained before and after addition
of oligomycin. The values reported are mean (±S.E.M.) of 6 independent
preparations. Two tailed Student's t test was applied to evaluate the
significance between the rates measured with the non induced (+TET) and
induced (−TET) cells. The P value for significant differences is shown. (B)
Imaging of ΔΨ-generating mitochondria by LSCM. Cells were seeded at
low density onto fibronectin coated 35 mm glass bottom dishes. After
adhesion, living cells were directly incubated for 20 min at 37 °C with
MitoCapture (1/1000 dilution). Stained cells were washed with PBS and
examined by a Nikon TE 2000 microscope (images collected using a 60X
objective 1.4 NA) coupled to a Radiance 2100 dual laser scanning confocal
microscopy system (Biorad). The fluorescent signal of the MitoCapture
double-emitter probe was examined sequentially, exciting first with the Ar–
Kr laser beam (λex=488 nm) and then with the He–Ne laser beam
(λex=543 nm). MitoCapture is a lipophilic cation that accumulates
electrophoretically in mitochondria; depending on the extent of the trans-
membrane electrical potential the dye accumulates as monomer (green
fluorescence emitter) or dimer (red fluorescence emitter, in iper-polarized
mitochondria). Magnification of selected areas (indicated by the white frame
are shown below each panel. The images are representative of five different
preparations. Scale bars: 20 μm. (C) Measurements of the specific activities
of NADH-CoQ oxidoreductase (CI), cytochrome c reductase (CIII) and
cytochrome c oxidase (CIV). The activities were determined spectrophoto-
metrically on mitoplast fraction of ultrasound-treated U-2 OS cells in
10 mM Tris, 1 mg/ml serum albumin, pH 7.4. CI was assayed (in the
presence of antimycin A plus KCN) by following the initial rotenone-
sensitive rate of NADH oxidation (ΔA at 340 nm) in the presence of UQ2
as electron acceptor; CIII was assayed (in the presence of rotenone plus
KCN) by following the initial antimycin A-sensitive rate of cytochrome c
reduction (ΔA at 550 nm) in the presence of UQ2 as electron donor; CIV
was assayed by following (in the presence of antimycin A) the initial KCN-
sensitive rate of cytochrome c oxidation (ΔA at 550 nm) under aerobic
conditions. The values reported for the induced cells (TET−) are expressed
as percentage of the non-induced (TET+) control cells. Averages (±S.E.M.)
of at least 5 different preparations; N.S., not significant.
Fig. 5. LSCM analysis of reactive oxygen species (ROS) production in non-induced and HCV-induced U-2 OS-derived cell line. Imaging of intracellular ROS
production by the O2
S− and H2O2 sensitive probes MitoSOX (A) and DCF (B) respectively. Cells were seeded at low density onto fibronectin coated 35 mm glass
bottom dishes. After adhesion, living cells were directly incubated for 20 min at 37 °C with 3 μMMitoSOX or 10 μM dichlorofluorescin-diacetate DCF-DA. Stained
cells were washed with PBS and examined as indicated in the legend to Fig. 5. The red fluorescence of MitoSOX, highly selective for detection of superoxide in
mitochondria of live cells, was monitored exciting with the He–Ne laser beam (λex=543 nm). DCF-DA is a membrane permeant probe which is hydrolised by
intracellular esterases and converted to the membrane-impermeant and ROS (mainly H2O2)-reacting product DCF. The green fluorescence of oxidised DCF was
analysed by exciting the sample with the Ar–Kr laser beam (λex=488 nm). Magnification of selected areas (indicated by the white frame are shown below each panel.
The images are representative of five different preparations. Scale bars: 20 μm.
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Fig. 6. Schematic working model for the mitochondrial dysfunction caused by
HCVinfection. Black-outlined boxes summarize the experimental evidence shown
in this work with the downward distribution of mitochondrial dysfunctions sug-
gesting a temporary progression of events. In blue possible connection with the
HCV-induced ER-stress via Ca2+ ER-efflux/mitochondrial overload is shown. See
text for further explanation.
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complex I is an enhanced electron leak, leading to
superoxide formation, we measured, next, the intracellular
reactive oxygen species production by specific probes. Fig.
5A shows that when assayed with MitoSox, a fluorescent
probe specific for O2
S− and that selectively accumulates in
the mitochondrial compartment, the HCV-induced U-2 OS
displayed a much higher signal than the non-induced cells.
The overproduction of superoxide in the induced cells was
also verified by the lucigenin–luminescence assay resulting
in a 3 fold increase of superoxide production with respect to
the basal level observed in the control cell (not shown).
Analysis carried out with the probe, DCF, more specifically
sensitive to H2O2, showed that in the induced cell, an even
more evident production of H2O2 occurred and that it nicely
localized to an intracellular compartment that resembled the
mitochondrial network. Interestingly the production of H2O2
was delayed with respect to the establishment of the
stationary level of the HCV proteins expression that was
already reached after only 6–12 h of induction (data not
shown). This would suggest an indirect effect of HCV
protein on the observed oxidative stress caused by preceding
alterations.
5. Aetiopathogenesis of HCV infection: a working hypothesis
A survey of the recent literature indicates that in cells
transiently transfected with subgenomic constructs, some ofthe HCV proteins partially co-localize with mitochondria or
are associated with a sub-fractions of mitochondrial
preparations containing markers of the endoplasmic reticu-
lum [10,12,13,18–24]. It has been shown by high resolution
3D reconstruction of confocal microscopy imaging that
endoplasmic reticulum and mitochondria form an intertwined
network with specific regions that are in tight contiguity
[25,26]. These contact sites have been proposed to provide
highly specialised areas enabling a functional/physical
interaction between the two membranous systems. In
particular, a localized calcium efflux from the ER into the
intermembrane space might be taken up by mitochondria
and used as signalling system [27,28]. In principle
conditions that alter this calcium connection between ER
and mitochondria can result in the deregulation of the
mitochondrial physiology [29–32].
Appraisal of the data available combined with the
evidence here reported tempts the proposal of the testable
working model schematically shown in Fig. 6. Accumulation
of HCV proteins in the ER membranes causes a local
depletion of calcium (possibly by opening the ER Ca++-
channels) that is electrogenically accumulated by mitochon-
dria causing depolarization of the membrane potential [33].
Although the increase of intramitochondrial calcium is
known to activate a number of dehydrogenases that provides
a prompt adaptative response to the stressing energy-
requiring condition [34,35], this reaction that is beneficial
if time controlled might instead results in deleterious effect
when the insult is chronically maintained as in the case of
the virus infection. High level of calcium can detach
cytochrome c from the cardiolipin inner membrane [36] and
activate the mitochondrial nitric oxide synthase with
production of NO [37,38] that is known to be an inhibitor
of complex IV [39,40] as well as of complex I [41]
although by a different mechanism. The combination of
these possible effects would result in an over-load of
harmful reducing equivalents throughout the respiratory
chain complexes and in an extra-production of ROS with
respect to the basal level [29,30]. Once exhausted the
buffering antioxidant capacity of glutathione and other redox
buffers a self-fuelling cycle can be activated with further
enhancement of reactive oxygen (nitrogen) species and
alteration of the mitochondrial homeostasis [42,43]. These
events, depending on the conditions, could, either culminate
in the actuation of the apoptotic program [29,44,45], thus
favouring diffusion of the virus infection or, paradoxically,
result in a carcinogenic prosurvival reaction of the host-cell
[46–49]. Pharmacological treatment of the infected cells
with compounds able to restore the mitochondrial calcium
homeostasis might prevent or even reverse the effects caused
by HCV [19].
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